Provider review
GetRelief Rx review
Says the price moves with your dose — then never publishes the ladder.
You cannot cost a low dose here before you pay, because the figure on the card is a floor and the rungs above it are not shown. There is no monthly plan either — two months is the minimum. Low, steady dosing is the whole pitch, which makes the gap harder to forgive.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
GetRelief Rx
$209/mo on a two-month minimum; the price moves with your dose
- Vs median
- $40/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Nobody will tell you what a quarter dose costs here. The price card carries "(pricing dependent on dosing)" right beside its figure, which is honest and useless in the same breath: the direction is stated, the ladder is not. That matters more here than almost anywhere, because low, steady dosing is the pitch — this is a daily sublingual product sold on the argument that you should not automatically climb to maintenance levels. Give it credit for what it does publish: a full list of the 34 states and Washington DC it serves, the medical director by name, and the whole subscription total beside every per-month figure. Two things will cost you if you misread them. There is no monthly plan at all, so the smallest purchase is two months charged together. And nothing on the site addresses whether a sublingual GLP-1 absorbs the way an injected one does.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You will not inject, and want a daily under-the-tongue route instead
- You want a provider whose own pitch is holding a low, steady dose rather than climbing
- You want your state confirmed in writing before you start an intake
- You can commit to two months at once
Look elsewhere if
- You need to know what a low dose costs before you pay. The figure quoted is a floor and the ladder is not published
- You want to pay for one month at a time. The smallest purchase is a two-month subscription
- You are comparing against a weekly injection — this is a daily product and the amounts are not stated in a comparable form
- You want evidence for the route before you buy. Sublingual absorption is never discussed
What it actually costs
Price as published
There is no month-to-month plan — the shortest commitment sold is two months · sublingual semaglutide $209/month, charged $418 for the two-month subscription; sublingual tirzepatide $359/month, charged $718 · six-month subscriptions $189/month ($1,134) and $319/month ($1,914) · every figure is a floor rather than a fixed rate: the price card itself says "(pricing dependent on dosing)" and the dose-by-dose ladder is not published anywhere · dosing is daily under the tongue rather than a weekly injection · both totals divide exactly by their advertised per-month figures
- Vs median
- $40/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. The site states that price depends on dose and then publishes only a starting figure, so the question this page exists to answer cannot be settled before you pay. It is also the one provider here selling a daily sublingual route and describing its own approach as low, steady dosing, which makes the missing ladder more frustrating rather than less.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Says out loud that the price depends on the dose — "(pricing dependent on dosing)" is printed on the price card rather than left for the invoice
- Positions itself on low, steady dosing rather than automatic escalation: "Our microdosing approach focuses on lower, steady dosing rather than automatically increasing to higher maintenance levels"
- Publishes its full state list — 34 states and Washington DC — in the footer of every page rather than claiming "most states"
- Prints the full subscription total beside the per-month figure, so the real commitment is visible before you buy
- Offers a daily sublingual route for a reader who will not inject
- Names its medical director with credentials
Pharmacy, labs and oversight
GetRelief Rx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What GetRelief Rx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
GetRelief Rx sells semaglutide and tirzepatide as a daily sublingual suspension rather than a weekly injection — "Not a Shot. Not a Tablet" — and positions the product explicitly around microdosing: "lower, steady dosing rather than automatically increasing to higher maintenance levels". It publishes a full list of the 34 states and Washington DC it serves, names its medical director, and sells only two-month and six-month subscriptions. The operating entity is Get Relief RX LLC in Billings, Montana. Prices are quoted as starting figures the site says depend on your dose, and the ladder behind them is not published.
The honest cons
THE DOSE-TO-PRICE LADDER IS NOT PUBLISHED. The card says pricing depends on dosing and then quotes one figure, so what a low dose actually costs cannot be worked out before you pay
- THERE IS NO MONTHLY PLAN. One page labels its cards "Monthly Plan Options", but every product is sold as a two-month or six-month subscription — the minimum commitment is two months and $418
- Sublingual absorption of semaglutide and tirzepatide is not addressed anywhere on the site, and no supporting data is cited for the route
- The navigation offers a "Medications & Pricing" section that leads to the site's own "Page Not Found"
- Product copy is mixed between molecules — the semaglutide listing includes a benefit written for dual GIP/GLP-1 therapy, and two benefit tiles are word-for-word identical across both drugs
- The compounding pharmacy is not named; the footer lists "GetRelief Pharmacy" as a partner without saying whether it is in-house or a third party
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
GetRelief Rx is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#104 of 373
Ordered with the companies that pay us first, and GetRelief Rx is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Low dose vs full dose
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.